To explore how tumor heterogeneity of HER2 expression within a single identical tumor model affects treatment response to chemotherapy, the correlation between HER2 expression level and PTX treatment efficacy within tumor models was quantified. The gene discussed is ERBB2; the disease is neoplasm.